Background <p>Crosstalk between inflammation and the immune system plays an important role in tumor malignant progression, immune evasion, and immunotherapy efficacy. This study aims to explore the significance of inflammation-associated gene ribosomal-binding protein 1 (RRBP1) in modulating tumor malignant progression and immune escape.</p> Methods <p>This study was used transcriptome, proteomic and in vivo anti-programmed death-ligand 1 (PD-L1) antibody CRISPR Cas9…
Targeting RRBP1 reverses immune evasion and enhances immunotherapy efficacy via the CXCL10-CXCR3 axis in bladder cancer
Journal for ImmunoTherapy of Cancer | | Shen, C., Liu, C., Hu, D., Ge, H., Li, C., Qin, R., Zhao, X., Wang, Y., Niu, H.
Topics: lung-cancer, bladder-cancer, immunotherapy, research
Read the full article at Journal for ImmunoTherapy of Cancer